These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
729 related articles for article (PubMed ID: 17466605)
1. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms. Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605 [TBL] [Abstract][Full Text] [Related]
2. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations. Shao Y; Alluri R; Mummert M; Koetter U; Lech S J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989 [TBL] [Abstract][Full Text] [Related]
3. A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules. Mohammadi A; Haririan I; Rezanour N; Ghiasi L; Walker RB J Chromatogr A; 2006 May; 1116(1-2):153-7. PubMed ID: 16603170 [TBL] [Abstract][Full Text] [Related]
4. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC. Jing Q; Shen Y; Tang Y; Ren F; Yu X; Hou Z J Pharm Biomed Anal; 2006 Jun; 41(3):1065-9. PubMed ID: 16545536 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms. Karakuş S; Küçükgüzel I; Küçükgüzel SG J Pharm Biomed Anal; 2008 Jan; 46(2):295-302. PubMed ID: 18054459 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms. Chaibva FA; Walker RB J Pharm Biomed Anal; 2007 Jan; 43(1):179-85. PubMed ID: 16920323 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form. den Brok MW; Nuijen B; Hillebrand MJ; Grieshaber CK; Harvey MD; Beijnen JH J Pharm Biomed Anal; 2005 Sep; 39(1-2):46-53. PubMed ID: 15899571 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations. Kyriakides D; Panderi I Anal Chim Acta; 2007 Feb; 584(1):153-9. PubMed ID: 17386598 [TBL] [Abstract][Full Text] [Related]
9. HPLC separation technique for analysis of bufuralol enantiomers in plasma and pharmaceutical formulations using a vancomycin chiral stationary phase and UV detection. Hefnawy MM; Sultan MA; Al-Shehri MM J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):328-36. PubMed ID: 17681871 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms. Thumma S; Zhang SQ; Repka MA Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002 [TBL] [Abstract][Full Text] [Related]
11. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681 [TBL] [Abstract][Full Text] [Related]
12. High performance liquid chromatographic analysis of dehydroepiandrosterone and its pharmaceutical tablet formulation. Aboul-Enein HY Biomed Chromatogr; 2004 Jan; 18(1):6-9. PubMed ID: 14872542 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a HPLC-UV method for the determination in didanosine tablets. de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304 [TBL] [Abstract][Full Text] [Related]
14. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant. Lalitha Devi M; Chandrasekhar KB J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations. Zaxariou M; Panderi I J Pharm Biomed Anal; 2004 Apr; 35(1):41-50. PubMed ID: 15030878 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms. Hadad GM; Emara S; Mahmoud WM Talanta; 2009 Oct; 79(5):1360-7. PubMed ID: 19635371 [TBL] [Abstract][Full Text] [Related]
17. A novel validated LC method for quantitation of lopinavir in bulk drug and pharmaceutical formulation in the presence of its potential impurities and degradation products. Seshachalam U; Haribabu B; Chandrasekhar K Biomed Chromatogr; 2007 Jul; 21(7):716-23. PubMed ID: 17370253 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a HPLC method for the determination of buprenorphine hydrochloride, naloxone hydrochloride and noroxymorphone in a tablet formulation. Mostafavi A; Abedi G; Jamshidi A; Afzali D; Talebi M Talanta; 2009 Feb; 77(4):1415-9. PubMed ID: 19084658 [TBL] [Abstract][Full Text] [Related]
20. A validated RP-HPLC method for the determination of mosapride citrate in bulk drug samples and pharmaceutical formulations. Krishnaiah YS; Murthy TK; Sankar DG; Satyanarayana V Pharmazie; 2002 Dec; 57(12):814-6. PubMed ID: 12561242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]